Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Treasury Shares (2016 - 2025)

Jaguar Health (JAGX) has disclosed Treasury Shares for 11 consecutive years, with $175713.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 79769.55% to $175713.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $175713.0 through Dec 2025, up 79769.55% year-over-year, with the annual reading at $175713.0 for FY2025, 79769.55% up from the prior year.
  • Treasury Shares for Q4 2025 was $175713.0 at Jaguar Health, up from $8408.0 in the prior quarter.
  • The five-year high for Treasury Shares was $3.5 million in Q1 2022, with the low at $22.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $690216.4, with a median of $28065.0 recorded in 2023.
  • The sharpest move saw Treasury Shares soared 6762252.0% in 2022, then tumbled 99.95% in 2025.
  • Over 5 years, Treasury Shares stood at $6499.0 in 2021, then plummeted by 99.66% to $22.0 in 2022, then skyrocketed by 8072.73% to $1798.0 in 2023, then tumbled by 87.76% to $220.0 in 2024, then skyrocketed by 79769.55% to $175713.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $175713.0, $8408.0, and $10434.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.